First experience with a transseptal puncture using a novel transseptal crossing device with integrated dilator and needle
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing(2022)
摘要
Background This study aimed to evaluate the feasibility and safety of an innovative “all in one” integrated transseptal crossing device to achieve transseptal puncture (TSP). Methods Twenty patients (10 males, mean age 65.65 ± 9.25 years), indicated to supraventricular left side tachyarrhythmia ablation, underwent TSP using a new-generation integrated crossing device, and a control cohort of twenty patients (10 males, mean age 65.5 ± 10.12 years) underwent TSP using the traditional TSP system. Results In all the study patients, the novel TSP device led to a successful and safe access to the left atrium (LA). The mean transseptal time, defined as the time occurring between the groin puncture and the advancing of the guidewire into the left superior pulmonary vein (PV), was 3 min 33 s ± 44 s, 7 min 5 s ± 36 s in the control cohort. Additionally, we compared the cost of the two systems. No acute complications related to the TSP were noted in both cohorts. Conclusions TSP performed with the new integrated transseptal system is feasible and safe.
更多查看译文
关键词
Ablation,Atrial fibrillation,Atrial septum,Transseptal puncture
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要